 |
Medical Chief, Mood, Anxiety and Impulsivity Disorders Program, Douglas Institute
serge_dot_beaulieu_At_mcgill_dot_ca |
2001
Baptista T., Beaulieu S. (2001). Glucose metabolism, schizophrenia, and antipsychotic drugs: comments to the paper of Dwyer et al, Ann Clin Psychiatry, 13(4), 241-2.
Baptista T., Beaulieu S. (2001). Body weight gain, insulin, and leptin in olanzapine-treated patients, J Clin Psychiatry, 62(11), 902-4.
Baptista T., Beaulieu S. (2001). Leptin and antipsychotic drugs, Br J Psychiatry, 179, 560-1.
Cyr M., Morissette M., Barden N., Beaulieu S., Rochford J., Di Paolo T. (2001). Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants, Neuroscience, 102(1), 151-8.
